Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial

International Journal of Stroke

Volumn 9, Issue 6, 2014, Pages 711-720

  Bath, Philip M W ^a   Adami, Alessandro ^b   Bereczki, Daniel ^c   Berge, Eivind ^d   Beridze, Maia ^e   Cala, Lesley ^f   Casado, Ana ^g   Caso, Valeria ^h   Chang, Hui Meng ⁱ   Christensen, Hanne ^j   Collins, Ronan ^k   Czlonkowska, Anna ^l   Dineen, Robert A ^a   Etribi, Anwar El ^m   Ghani, AbdulRahman ⁿ   Gommans, John ^o   Koumellis, Panos ^p   Laska, Ann Charlotte ^q   Lees, Kennedy R ^r   Navarro, Jose ^s   Ntaios, George ^t   Ozturk, Serefnur ^u   Phillips, Stephen ^v   Pocock, Stuart ^w   Prasad, Kameshwar ^x   Scutt, Polly ^a   de Silva, H Asita ^y   Szatmari, Szabolcs ^z   Exuperio Diez Tejedor ^aa   Utton, Sally ^a   Wang, Yong Jun ^ab   Joanna M Wardlaw, ^g   Whynes, David ^a   Wong, Lawrence ^ac   Woodhouse, Lisa ^a   Sprigg, Nikola ^a   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Hospital of War Veterans   (Georgia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h UNIVERSITY OF PERUGIA   (Italy)

ⁱ SINGAPORE GENERAL HOSPITAL   (Singapore)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k ADELAIDE AND MEATH HOSPITAL   (Ireland)

^l INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^m AIN SHAMS UNIVERSITY   (Egypt)

ⁿ HOSPITAL UNIVERSITI SAINS MALAYSIA   (Malaysia)

^o HAWKE S BAY HOSPITAL   (New Zealand)

^p PRINCESS ROYAL HOSPITAL   (United Kingdom)

^q KAROLINSKA INSTITUTE   (Sweden)

^r UNIVERSITY OF GLASGOW   (United Kingdom)

^s Jose R Reyes Memorial Medical Center   (Philippines)

^t UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^u SELCUK UNIVERSITY   (Turkey)

^v QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^w LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^x ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^y UNIVERSITY OF KELANIYA   (Sri Lanka)

^z Hematology Department   (Romania)

^aa UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^ab CAPITAL MEDICAL UNIVERSITY   (China)

^ac CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Acute stroke; Antihypertensive drugs; Blood pressure; Glyceryl trinitrate; Nitric oxide; Randomized controlled trial

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; NITRIC OXIDE; RENIN INHIBITOR; VASOACTIVE AGENT; ANTIHYPERTENSIVE AGENT; VASODILATOR AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CEREBRAL HEMORRHAGE; CLINICAL TRIAL; CUTANEOUS DRUG ADMINISTRATION; DRUG EFFECTS; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STROKE; TREATMENT OUTCOME; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84904697747     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12308     Document Type: Article

References (39)

1. Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG, for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33:1315-1320.
2. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004; 43:18-24.
3. Sprigg N, Gray LJ, Bath PM etal. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens 2006; 24:1413-1417.
4. Geeganage C, Tracy M, England T etal. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST). Stroke 2011; 42:491-493.
5. Hacke W, Ringleb PA, Bousser MG etal. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 - The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Cerebrovasc Dis 2008; 25:457-507.
6. Anderson CS, Heeley E, Huang Y etal. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368:2355-2365.
7. Willmot MR, Bath PMW. The potential of nitric oxide therapeutics in stroke. Expert Opin Investig Drugs 2003; 12:455-470.
8. Willmot M, Murphy S, Leonardi-Bee J, Bath P. Systematic review of nitric oxide donors and L-arginine in experimental stroke: effects on infarct size and cerebral blood flow. Cerebrovasc Dis 2003; 16:S3 66, abstract.
9. Butterworth RJ, Cluckie A, Jackson SHD, Buxton-Thomas M, Bath PMW. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998; 8:158-165.
10. Bath PMW, Pathansali R, Iddenden R, Bath FJ. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 2001; 11:265-272.
11. Rashid P, Weaver C, Leonardi-Bee JA, Fletcher S, Bath FJ, Bath PMW. The effects of transdermal glyceryl trinitrate, a nitric oxide donor on blood pressure, cerebral and cardiac haemodynamics and plasma nitric oxide levels in acute stroke. J Stroke Cerebrovasc Dis 2003; 13:143-151.
12. Willmot M, Ghadami A, Whysall B, Clarke W, Wardlaw J, Bath PM. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006; 47:1209-1215.
13. Ankolekar S, Fuller M, Cross I etal. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in hypertensive stroke trial (RIGHT, ISRCTN66434824). Stroke 2013; 44:3120-3128.
14. Bath PMW, Willmot M, Bath-Hextall FJ, Leonardie-Bee J. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors in acute ischaemic stroke. Cochrane Database Syst Rev 2002; (4):CD000398.
15. Geeganage C, Bath PMW. Interventions for deliberately altering blood pressure in acute stroke (Review). Cochrane Database Syst Rev 2008; (4):CD000039.
16. Geeganage C, Bath PM. Vasoactive drugs for acute stroke. Cochrane Database Syst Rev 2010; (7):CD002839.
17. Gray LJ, Sprigg N, Rashid PA, Willmot M, Bath PMW. Effect of nitric oxide donors on blood pressure and pulse pressure in acute and sub-acute stroke. J Stroke Cerebrovasc Dis 2006; 15:245-249.
18. Geeganage CM, Bath AJ, Bath PM. The effect of transdermal glyceryl trinitrate on 24 h ambulatory blood pressure in acute/subacute stroke. Int J Stroke 2011; 6:290-294.
19. Lees KR, Dyker AG. Blood pressure control after acute stroke. J Hypertens 1996; 14(Suppl. 6):S35-38.
20. COSSACS Trial Group. COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design. J Hypertens 2005; 23:455-458.
21. Robinson TG, Potter JF, Ford GA etal. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol 2010; 9:767-775.
22. The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 2006; 1:245-249.
23. Gray LJ, Ali M, Lyden PD, Bath PMW. VISTA Collaborators. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis 2009; 18:466-468.
24. Weir CJ, Lees KR. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. Stat Med 2003; 22:705-726.
25. Bath PM, Houlton A, Woodhouse L, Sprigg N, Wardlaw J, Pocock S; on behalf of the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. Int J Stroke 2013; 9:372-374.
26. De Silva DA, Omar E, Manzano JJ etal. Comparison of small volume infarcts of lacunar and non-lacunar etiologies. Int J Stroke 2013; 8:E24-25.
27. The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? Statistical re-analysis of functional outcomes in stroke trials. Stroke 2007; 38:1911-1915.
28. Bath PM, Lees KR, Schellinger PD etal. Statistical analysis of the primary outcome in acute stroke trials. Stroke 2012; 43:1171-1178.
29. The Optimising Analysis of Stroke Trials (OAST) Collaboration. Should stroke trials adjust functional outcome for baseline prognostic factors? Stroke 2009; 40:888-894.
30. Saver JL. Novel-end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke 2007; 38:3055-3062.
31. Savitz SI, Lew R, Bluhmki E, Hacke W, Fisher M. Shift analysis versus dichotomization of the Modified Rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke 2007; 38:3205-3212.
32. Lees KR, Zivin JA, Ashwood T etal. NXY-059 for acute ischemic stroke. NEJM 2006; 354:588-599.
33. Kobayashi A, Grabska K, Czlonkowska A, Gray LJ, Bath PMW. Efficacy of Nitric Oxide in Stroke - ENOS - a randomized trial - characteristics of patients recruited in Poland. Neurol Neurochir Pol 2008; 42:99-104.
34. Ildiko SSS, Jurcau A, Simion A etal. The efficacy of nitric oxide in stroke (ENOS) Trial - where do we stand in Romania? Rom J Neurol 2012; XI:68-74.
35. Gray LJ, Ali M, Lyden PD, Bath PM. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis 2009; 18:466-468.
36. Sandset EC, Bath PM, Boysen G etal. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011; 377:741-750.
37. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004; 363:439-445.
38. Sanossian N, Starkman S, Liebeskind DS etal. Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis 2009; 28:539-544.
39. He J, Zhang Y, Xu T etal. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA 2014; 311:479-489.